ID   T2FA_HUMAN              Reviewed;         517 AA.
AC   P35269; B2RCS0; Q9BWN0;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=General transcription factor IIF subunit 1;
DE   AltName: Full=General transcription factor IIF 74 kDa subunit;
DE   AltName: Full=Transcription initiation factor IIF subunit alpha;
DE            Short=TFIIF-alpha;
DE   AltName: Full=Transcription initiation factor RAP74;
GN   Name=GTF2F1; Synonyms=RAP74;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1734283; DOI=10.1038/355461a0;
RA   Aso T., Vasavada H.A., Kawaguchi T., Germino F.J., Ganguly S.,
RA   Kitajima S., Weissman S.M., Yasukochi Y.;
RT   "Characterization of cDNA for the large subunit of the transcription
RT   initiation factor TFIIF.";
RL   Nature 355:461-464(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1734284; DOI=10.1038/355464a0;
RA   Finkelstein A., Kostrub C.F., Li J., Chavez D.P., Wang B.Q.,
RA   Fang S.M., Greenblatt J., Burton Z.F.;
RT   "A cDNA encoding RAP74, a general initiation factor for transcription
RT   by RNA polymerase II.";
RL   Nature 355:464-467(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH TAF6.
RX   PubMed=7667268; DOI=10.1073/pnas.92.18.8195;
RA   Hisatake K., Ohta T., Takada R., Guermah M., Horikoshi M.,
RA   Nakatani Y., Roeder R.G.;
RT   "Evolutionary conservation of human TATA-binding-polypeptide-
RT   associated factors TAFII31 and TAFII80 and interactions of TAFII80
RT   with other TAFs and with general transcription factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8195-8199(1995).
RN   [8]
RP   PHOSPHORYLATION AT SERINE RESIDUES.
RX   PubMed=8625415; DOI=10.1016/S0092-8674(00)81055-7;
RA   Dikstein R., Ruppert S., Tjian R.;
RT   "TAFII250 is a bipartite protein kinase that phosphorylates the base
RT   transcription factor RAP74.";
RL   Cell 84:781-790(1996).
RN   [9]
RP   FUNCTION, PHOSPHORYLATION AT SER-385 AND THR-389, AND MUTAGENESIS OF
RP   SER-385 AND THR-389.
RX   PubMed=10428810; DOI=10.1074/jbc.274.32.22387;
RA   Rossignol M., Keriel A., Staub A., Egly J.-M.;
RT   "Kinase activity and phosphorylation of the largest subunit of TFIIF
RT   transcription factor.";
RL   J. Biol. Chem. 274:22387-22392(1999).
RN   [10]
RP   INTERACTION WITH URI1.
RX   PubMed=12737519; DOI=10.1038/sj.cr.7290155;
RA   Wei W., Gu J.X., Zhu C.Q., Sun F.Y., Dorjsuren D., Lin Y.,
RA   Murakami S.;
RT   "Interaction with general transcription factor IIF (TFIIF) is required
RT   for the suppression of activated transcription by RPB5-mediating
RT   protein (RMP).";
RL   Cell Res. 13:111-120(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217; SER-218; SER-221
RP   AND SER-224, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   INDUCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells
RT   reveal differential cellular gene expression in response to
RT   enterovirus 71 infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377; SER-380; SER-381;
RP   SER-385; THR-389; SER-431; SER-433; SER-436; THR-446 AND SER-449, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217; SER-385 AND
RP   THR-389, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-407, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217; SER-218; SER-221;
RP   SER-224 AND SER-433, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217; SER-218; SER-224;
RP   THR-331; SER-385 AND SER-391, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-156; SER-377; SER-385;
RP   THR-389; SER-431; SER-433 AND THR-437, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 5-153 IN COMPLEX WITH GTF2F2.
RX   PubMed=11183778; DOI=10.1006/jmbi.2000.4110;
RA   Gaiser F., Tan S., Richmond T.J.;
RT   "Novel dimerization fold of RAP30/RAP74 in human TFIIF at 1.7 A
RT   resolution.";
RL   J. Mol. Biol. 302:1119-1127(2000).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.02 ANGSTROMS) OF 451-517.
RX   PubMed=11248041; DOI=10.1073/pnas.051631098;
RA   Kamada K., De Angelis J., Roeder R.G., Burley S.K.;
RT   "Crystal structure of the C-terminal domain of the RAP74 subunit of
RT   human transcription factor IIF.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3115-3120(2001).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 449-517 IN COMPLEX WITH
RP   CTDP1.
RX   PubMed=12591941; DOI=10.1073/pnas.262798199;
RA   Kamada K., Roeder R.G., Burley S.K.;
RT   "Molecular mechanism of recruitment of TFIIF-associating RNA
RT   polymerase C-terminal domain phosphatase (FCP1) by transcription
RT   factor IIF.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2296-2299(2003).
RN   [28]
RP   STRUCTURE BY NMR OF 451-517.
RX   PubMed=12578358; DOI=10.1021/bi0265473;
RA   Nguyen B.D., Chen H.T., Kobor M.S., Greenblatt J., Legault P.,
RA   Omichinski J.G.;
RT   "Solution structure of the carboxyl-terminal domain of RAP74 and NMR
RT   characterization of the FCP1-binding sites of RAP74 and human TFIIB.";
RL   Biochemistry 42:1460-1469(2003).
RN   [29]
RP   STRUCTURE BY NMR OF 451-517.
RX   PubMed=12732728; DOI=10.1073/pnas.1031524100;
RA   Nguyen B.D., Abbott K.L., Potempa K., Kobor M.S., Archambault J.,
RA   Greenblatt J., Legault P., Omichinski J.G.;
RT   "NMR structure of a complex containing the TFIIF subunit RAP74 and the
RT   RNA polymerase II carboxyl-terminal domain phosphatase FCP1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:5688-5693(2003).
CC   -!- FUNCTION: TFIIF is a general transcription initiation factor that
CC       binds to RNA polymerase II and helps to recruit it to the
CC       initiation complex in collaboration with TFIIB. It promotes
CC       transcription elongation. {ECO:0000269|PubMed:10428810}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Interacts
CC       with GTF2F2, CTDP1, TAF6/TAFII80 and URI1.
CC       {ECO:0000269|PubMed:11183778, ECO:0000269|PubMed:12591941,
CC       ECO:0000269|PubMed:12737519, ECO:0000269|PubMed:7667268}.
CC   -!- INTERACTION:
CC       P21675:TAF1; NbExp=3; IntAct=EBI-457886, EBI-491289;
CC       O94763:URI1; NbExp=3; IntAct=EBI-457886, EBI-357067;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- INDUCTION: Up-regulated in response to enterovirus 71 (EV71)
CC       infection. {ECO:0000269|PubMed:16548883}.
CC   -!- PTM: Phosphorylated on Ser and other residues by TAF1 and casein
CC       kinase II-like kinases. {ECO:0000269|PubMed:10428810,
CC       ECO:0000269|PubMed:8625415}.
CC   -!- SIMILARITY: Belongs to the TFIIF alpha subunit family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was reported to have a protein kinase activity and to
CC       autophosphorylates on Ser-385 and Thr-389.
CC       {ECO:0000305|PubMed:10428810}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X64037; CAA45408.1; -; mRNA.
DR   EMBL; X64002; CAA45404.1; -; mRNA.
DR   EMBL; BT007097; AAP35761.1; -; mRNA.
DR   EMBL; AK315240; BAG37667.1; -; mRNA.
DR   EMBL; CH471139; EAW69098.1; -; Genomic_DNA.
DR   EMBL; BC000120; AAH00120.1; -; mRNA.
DR   EMBL; BC013007; AAH13007.1; -; mRNA.
DR   CCDS; CCDS12165.1; -.
DR   PIR; S20248; S20248.
DR   RefSeq; NP_002087.2; NM_002096.2.
DR   UniGene; Hs.68257; -.
DR   PDB; 1F3U; X-ray; 1.70 A; B/D/F/H=2-172.
DR   PDB; 1I27; X-ray; 1.02 A; A=449-517.
DR   PDB; 1J2X; X-ray; 2.00 A; A=449-517.
DR   PDB; 1NHA; NMR; -; A=436-517.
DR   PDB; 1ONV; NMR; -; A=436-517.
DR   PDB; 2K7L; NMR; -; A=451-517.
DR   PDB; 5IY6; EM; 7.20 A; S=1-517.
DR   PDB; 5IY7; EM; 8.60 A; S=1-517.
DR   PDB; 5IY8; EM; 7.90 A; S=1-517.
DR   PDB; 5IY9; EM; 6.30 A; S=1-517.
DR   PDB; 5IYA; EM; 5.40 A; S=1-517.
DR   PDB; 5IYB; EM; 3.90 A; S=1-517.
DR   PDB; 5IYC; EM; 3.90 A; S=1-517.
DR   PDB; 5IYD; EM; 3.90 A; S=1-517.
DR   PDBsum; 1F3U; -.
DR   PDBsum; 1I27; -.
DR   PDBsum; 1J2X; -.
DR   PDBsum; 1NHA; -.
DR   PDBsum; 1ONV; -.
DR   PDBsum; 2K7L; -.
DR   PDBsum; 5IY6; -.
DR   PDBsum; 5IY7; -.
DR   PDBsum; 5IY8; -.
DR   PDBsum; 5IY9; -.
DR   PDBsum; 5IYA; -.
DR   PDBsum; 5IYB; -.
DR   PDBsum; 5IYC; -.
DR   PDBsum; 5IYD; -.
DR   ProteinModelPortal; P35269; -.
DR   SMR; P35269; -.
DR   BioGrid; 109217; 98.
DR   DIP; DIP-677N; -.
DR   IntAct; P35269; 21.
DR   MINT; MINT-1403790; -.
DR   STRING; 9606.ENSP00000377969; -.
DR   iPTMnet; P35269; -.
DR   PhosphoSitePlus; P35269; -.
DR   BioMuta; GTF2F1; -.
DR   DMDM; 46397744; -.
DR   EPD; P35269; -.
DR   MaxQB; P35269; -.
DR   PaxDb; P35269; -.
DR   PeptideAtlas; P35269; -.
DR   PRIDE; P35269; -.
DR   TopDownProteomics; P35269; -.
DR   DNASU; 2962; -.
DR   Ensembl; ENST00000394456; ENSP00000377969; ENSG00000125651.
DR   GeneID; 2962; -.
DR   KEGG; hsa:2962; -.
DR   UCSC; uc002meq.3; human.
DR   CTD; 2962; -.
DR   DisGeNET; 2962; -.
DR   GeneCards; GTF2F1; -.
DR   HGNC; HGNC:4652; GTF2F1.
DR   HPA; HPA022793; -.
DR   HPA; HPA028707; -.
DR   MIM; 189968; gene.
DR   neXtProt; NX_P35269; -.
DR   OpenTargets; ENSG00000125651; -.
DR   PharmGKB; PA29038; -.
DR   eggNOG; KOG2393; Eukaryota.
DR   eggNOG; ENOG410XSRW; LUCA.
DR   GeneTree; ENSGT00440000038032; -.
DR   HOGENOM; HOG000059644; -.
DR   HOVERGEN; HBG000729; -.
DR   InParanoid; P35269; -.
DR   KO; K03138; -.
DR   OMA; PERKMIS; -.
DR   OrthoDB; EOG091G0N3J; -.
DR   PhylomeDB; P35269; -.
DR   TreeFam; TF313850; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-112387; Elongation arrest and recovery.
DR   Reactome; R-HSA-113418; Formation of the Early Elongation Complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167158; Formation of the HIV-1 Early Elongation Complex.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-167161; HIV Transcription Initiation.
DR   Reactome; R-HSA-167162; RNA Polymerase II HIV Promoter Escape.
DR   Reactome; R-HSA-167172; Transcription of the HIV genome.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167242; Abortive elongation of HIV-1 transcript in the absence of Tat.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6803529; FGFR2 alternative splicing.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72165; mRNA Splicing - Minor Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-HSA-73776; RNA Polymerase II Promoter Escape.
DR   Reactome; R-HSA-73779; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening.
DR   Reactome; R-HSA-75953; RNA Polymerase II Transcription Initiation.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   Reactome; R-HSA-76042; RNA Polymerase II Transcription Initiation And Promoter Clearance.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   Reactome; R-HSA-8851708; Signaling by FGFR2 IIIa TM.
DR   SIGNOR; P35269; -.
DR   ChiTaRS; GTF2F1; human.
DR   EvolutionaryTrace; P35269; -.
DR   GeneWiki; GTF2F1; -.
DR   GenomeRNAi; 2962; -.
DR   PMAP-CutDB; P35269; -.
DR   PRO; PR:P35269; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000125651; -.
DR   CleanEx; HS_GTF2F1; -.
DR   ExpressionAtlas; P35269; baseline and differential.
DR   Genevisible; P35269; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0005669; C:transcription factor TFIID complex; IDA:UniProtKB.
DR   GO; GO:0005674; C:transcription factor TFIIF complex; TAS:ProtInc.
DR   GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0019211; F:phosphatase activator activity; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:CAFA.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IEA:InterPro.
DR   GO; GO:0050434; P:positive regulation of viral transcription; TAS:Reactome.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   GO; GO:0042795; P:snRNA transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR008851; TFIIF-alpha.
DR   InterPro; IPR011039; TFIIF_interaction.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF05793; TFIIF_alpha; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF50916; SSF50916; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    517       General transcription factor IIF subunit
FT                                1.
FT                                /FTId=PRO_0000211231.
FT   COMPBIAS    283    350       Glu-rich.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     156    156       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     217    217       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     218    218       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     221    221       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     224    224       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     331    331       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     380    380       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     381    381       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     385    385       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:10428810}.
FT   MOD_RES     389    389       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:10428810}.
FT   MOD_RES     391    391       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     407    407       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     431    431       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     433    433       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     436    436       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     437    437       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     446    446       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     449    449       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VARIANT       3      3       A -> V (in dbSNP:rs34826931).
FT                                /FTId=VAR_039004.
FT   MUTAGEN     385    385       S->A: Eliminates putative kinase
FT                                activity; when associated with A-389.
FT                                {ECO:0000269|PubMed:10428810}.
FT   MUTAGEN     389    389       T->A: Eliminates putative kinase
FT                                activity; when associated with A-385.
FT                                {ECO:0000269|PubMed:10428810}.
FT   CONFLICT    231    231       V -> I (in Ref. 2; CAA45404).
FT                                {ECO:0000305}.
FT   CONFLICT    361    361       L -> F (in Ref. 1; CAA45408).
FT                                {ECO:0000305}.
FT   STRAND       10     17       {ECO:0000244|PDB:1F3U}.
FT   STRAND       23     31       {ECO:0000244|PDB:1F3U}.
FT   HELIX        33     35       {ECO:0000244|PDB:1F3U}.
FT   HELIX        39     41       {ECO:0000244|PDB:1F3U}.
FT   STRAND       45     49       {ECO:0000244|PDB:1F3U}.
FT   HELIX        52     55       {ECO:0000244|PDB:1F3U}.
FT   STRAND       58     61       {ECO:0000244|PDB:1F3U}.
FT   HELIX        76     78       {ECO:0000244|PDB:1F3U}.
FT   STRAND       84     87       {ECO:0000244|PDB:1F3U}.
FT   STRAND       98    104       {ECO:0000244|PDB:1F3U}.
FT   STRAND      109    114       {ECO:0000244|PDB:1F3U}.
FT   STRAND      120    129       {ECO:0000244|PDB:1F3U}.
FT   STRAND      135    148       {ECO:0000244|PDB:1F3U}.
FT   HELIX       149    151       {ECO:0000244|PDB:1F3U}.
FT   HELIX       157    167       {ECO:0000244|PDB:1F3U}.
FT   HELIX       456    465       {ECO:0000244|PDB:1I27}.
FT   HELIX       470    475       {ECO:0000244|PDB:1I27}.
FT   HELIX       479    482       {ECO:0000244|PDB:1I27}.
FT   HELIX       486    500       {ECO:0000244|PDB:1I27}.
FT   STRAND      503    507       {ECO:0000244|PDB:1I27}.
FT   STRAND      510    515       {ECO:0000244|PDB:1I27}.
SQ   SEQUENCE   517 AA;  58240 MW;  1032B04A36BDC24F CRC64;
     MAALGPSSQN VTEYVVRVPK NTTKKYNIMA FNAADKVNFA TWNQARLERD LSNKKIYQEE
     EMPESGAGSE FNRKLREEAR RKKYGIVLKE FRPEDQPWLL RVNGKSGRKF KGIKKGGVTE
     NTSYYIFTQC PDGAFEAFPV HNWYNFTPLA RHRTLTAEEA EEEWERRNKV LNHFSIMQQR
     RLKDQDQDED EEEKEKRGRR KASELRIHDL EDDLEMSSDA SDASGEEGGR VPKAKKKAPL
     AKGGRKKKKK KGSDDEAFED SDDGDFEGQE VDYMSDGSSS SQEEPESKAK APQQEEGPKG
     VDEQSDSSEE SEEEKPPEED KEEEEEKKAP TPQEKKRRKD SSEESDSSEE SDIDSEASSA
     LFMAKKKTPP KRERKPSGGS SRGNSRPGTP SAEGGSTSST LRAAASKLEQ GKRVSEMPAA
     KRLRLDTGPQ SLSGKSTPQP PSGKTTPNSG DVQVTEDAVR RYLTRKPMTT KDLLKKFQTK
     KTGLSSEQTV NVLAQILKRL NPERKMINDK MHFSLKE
//
